These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31253317)

  • 21. Lactose in dairy ingredients: Effect on processing and storage stability.
    Huppertz T; Gazi I
    J Dairy Sci; 2016 Aug; 99(8):6842-6851. PubMed ID: 26387022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of particle morphology on the triboelectrification in dry powder inhalers.
    Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
    Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hydrolysis on solid-state relaxation and stickiness behavior of sodium caseinate-lactose powders.
    Mounsey JS; Hogan SA; Murray BA; O'Callaghan DJ
    J Dairy Sci; 2012 May; 95(5):2270-81. PubMed ID: 22541456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallization kinetics of amorphous lactose, whey-permeate and whey powders.
    Ibach A; Kind M
    Carbohydr Res; 2007 Jul; 342(10):1357-65. PubMed ID: 17445785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of breakage behavior and its effects on spray-dried agglomerated whey protein-lactose powders: Effect of protein and lactose contents.
    Han J; Fitzpatrick J; Cronin K; Maidannyk V; Miao S
    J Dairy Sci; 2022 Nov; 105(11):8750-8764. PubMed ID: 36153160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fat properties during homogenization, spray-drying, and storage affect the physical properties of dairy powders.
    Vignolles ML; Lopez C; Madec MN; Ehrhardt JJ; Méjean S; Schuck P; Jeantet R
    J Dairy Sci; 2009 Jan; 92(1):58-70. PubMed ID: 19109263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invited review: spray-dried dairy and dairy-like emulsions--compositional considerations.
    Vega C; Roos YH
    J Dairy Sci; 2006 Feb; 89(2):383-401. PubMed ID: 16428609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technological aspects of lactose-hydrolyzed milk powder.
    Torres JKF; Stephani R; Tavares GM; de Carvalho AF; Costa RGB; de Almeida CER; Almeida MR; de Oliveira LFC; Schuck P; Perrone ÍT
    Food Res Int; 2017 Nov; 101():45-53. PubMed ID: 28941696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    Sethuraman VV; Hickey AJ
    AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of lactose crystallization and color changes in model infant foods.
    Nasirpour A; Scher J; Linder M; Desobry S
    J Dairy Sci; 2006 Jul; 89(7):2365-73. PubMed ID: 16772552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of load on particle size distribution of lactose-crystalline cellulose mixed powder.
    Nakamori T; Miyagishim A; Nozawa Y; Sadzuka Y; Sonobe T
    Int J Pharm; 2008 Apr; 354(1-2):255-9. PubMed ID: 18258396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
    Ziffels S; Steckel H
    Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short communication: Multi-component interactions causing solidification during industrial-scale manufacture of pre-crystallized acid whey powders.
    Drapala KP; Murphy KM; Ho QT; Crowley SV; Mulcahy S; McCarthy NA; O'Mahony JA
    J Dairy Sci; 2018 Dec; 101(12):10743-10749. PubMed ID: 30292547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW; Lim LT; Heng PW
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactose/beta-lactoglobulin interaction during storage of model whey powders.
    Thomas ME; Scher J; Desobry S
    J Dairy Sci; 2004 May; 87(5):1158-66. PubMed ID: 15290962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of amorphous content by microcalorimetry.
    Kawakami K; Numa T; Ida Y
    J Pharm Sci; 2002 Feb; 91(2):417-23. PubMed ID: 11835201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.